Header cover image

Brazilian Pharmaceuticals & Biotech Price disconnect

Results

2

1 new

Stocks which the market has priced substantially different to their cash flows, which could imply risk.

2 companies

Hypera

Market Cap: R$15.2b

Operates as a pharmaceutical company in Brazil.

HYPE3

R$21.57

7D

1.1%

1Y

-6.2%

Ouro Fino Saúde Animal Participações

Market Cap: R$1.4b

Engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals primarily in Brazil.

New

OFSA3

R$25.99

7D

-5.7%

1Y

13.5%